Organization Overview
Alternative names
acetaminophen (tylenol) (3 trials)
acetylcysteine (mucomyst) (2 trials)
amiloride (midamor) (2 trials)
atorvastatin (lipitor) (2 trials)
azithromycin (zithromax) (1 trial)
estradiol (progynon depot) (1 trial)
ethinyl estradiol (Estinyl) (1 trial)
fenofibrate (fenoglide) (1 trial)
fibrinogen (human) (RiaSTAP) (1 trial)
albumin (Human) (Plasbumin) (1 trial)
albuterol (proventil) (1 trial)
allogeneic lymphocytes (1 trial)
alteplase (Activase) (2 trials)
amlodipine (norvasc) (1 trial)
autologous hematopoietic stem cells (1 trial)
chlorhexidine (hibitane) (1 trial)
cilostazol (pletal) (2 trials)
cladribine (leustatin) (1 trial)
clonidine (catapres) (1 trial)
colchicine (colbenemid) (1 trial)
cyclophosphamide (cytoxan) (2 trials)
dexmedetomidine (precedex) (1 trial)
doxorubicin (Doxil) (3 trials)
ferumoxytol (feraheme) (1 trial)
fluorouracil (efudex) (2 trials)
glyburide (micronase) (1 trial)
hydroxychloroquine (plaquenil) (1 trial)
hydroxyurea (hydrea) (1 trial)
icosapent ethyl (vascepa) (2 trials)
insulin human (humulin) (2 trials)
interferon alpha-2b (Intron-A) (1 trial)
magnesium sulfate (Tis-U-Sol) (1 trial)
mifepristone (mifeprex) (1 trial)
nafamostat (ronastat) (1 trial)
nimodipine (nimotop) (1 trial)
norepinephrine (levophed) (3 trials)
oxycodone (oxycontin) (1 trial)
phenindione (hedulin) (1 trial)
povidone-iodine (betadine) (1 trial)
rivaroxaban (xarelto) (2 trials)
rocuronium (zemuron) (1 trial)
sargramostim (leukine) (1 trial)
simvastatin (zocor) (2 trials)
sugammadex (bridion) (1 trial)
tamoxifen (nolvadex) (1 trial)
temsirolimus (torisel) (2 trials)
tenecteplase (tnkase) (1 trial)
ticagrelor (brilinta) (1 trial)
alendronic acid (fosamax) (1 trial)
cabazitaxel (jevtana kit) (1 trial)
capecitabine (xeloda) (1 trial)
acetylcholine chloride (miochol) (1 trial)
acetylsalicylic acid (aspirin) (3 trials)
autologous endorem-labelled mononuclear cells (2 trials)
dapagliflozin (farxiga) (1 trial)
ferumoxides (feridex I.V.) (2 trials)
fluconazole (diflucan) (1 trial)
fludeoxyglucose f-18 (1 trial)
hydralazine (apresoline) (1 trial)
Abortion, Missed (Phase 3)
Abortion, Spontaneous (Phase 3)
Acute Kidney Injury (Phase 2)
Acute Lung Injury (Phase 2)
Altitude Sickness (Phase 4)
Amyotrophic Lateral Sclerosis (Phase 3)
Aneurysm (Phase 4)
Angina Pectoris (Phase 4)
Aortic Aneurysm (Phase 3)
Aortic Aneurysm, Abdominal (Phase 4)
Aortic Valve Stenosis (Phase 2)
Atrial Fibrillation (Phase 3)
Atrial Flutter (Phase 3)
Autism Spectrum Disorder (Phase 2)
Bile Duct Neoplasms (Phase 2)
Blood Coagulation Disorders (Phase 4)
Breast Neoplasms (Phase 3)
Bronchiectasis (Phase 4)
Calcinosis (Phase 2)
Cancer Pain (Phase 3)
Carcinoma (Phase 3)
Carcinoma, Hepatocellular (Phase 3)
Carcinoma, Non-Small-Cell Lung (Phase 2)
Carcinoma, Ovarian Epithelial (Phase 3)
Cardio-Renal Syndrome (Phase 4)
Cerebral Small Vessel Diseases (Phase 3)
Cerebrovascular Disorders (Phase 3)
Cognitive Dysfunction (Phase 2)
Colitis (Phase 2)
Colitis, Ulcerative (Phase 2)
Colorectal Neoplasms (Phase 2)
Communicable Diseases (Phase 3)
Constriction, Pathologic (Phase 2)
Coronary Artery Disease (Phase 3)
Coronavirus Infections (Phase 3)
Critical Illness (Phase 3)
Cystic Fibrosis (Phase 2)
Cysts (Phase 4)
Delayed Graft Function (Phase 3)
Diabetes, Gestational (Phase 3)
Diabetes Mellitus (Phase 3)
Diabetes Mellitus, Type 2 (Phase 2)
Diabetic Retinopathy (Phase 4)
Drug Overdose (Phase 1)
Emergencies (Phase 2)
Fatty Liver (Phase 3)
Fibrosis (Phase 2)
Ganglion Cysts (Phase 4)
Gastrointestinal Neoplasms (Phase 2)
Hematoma (Phase 3)
Hematoma, Subdural (Phase 3)
Hemorrhage (Phase 3)
Hemostatic Disorders (Phase 4)
Hepatitis (Phase 1)
Hepatitis A (Phase 1)
Hepatitis C, Chronic (Phase 1)
Hypersensitivity (Phase 3)
Hypertension (Phase 4)
Hypertension, Portal (Phase 2)
Infections (Phase 3)
Inflammation (Phase 3)
Influenza, Human (Phase 4)
Intracranial Hemorrhage, Hypertensive (Phase 3)
Intracranial Hemorrhages (Phase 3)
Ischemia (Phase 3)
Ischemic Attack, Transient (Phase 3)
Kidney Diseases (Phase 4)
Leiomyoma (Phase 4)
Leukemia (Phase 3)
Leukemia, Myeloid (Phase 3)
Liposarcoma (Phase 2)
Liver Cirrhosis (Phase 2)
Liver Diseases (Phase 3)
Liver Neoplasms (Phase 3)
Lung Injury (Phase 2)
Lymphoproliferative Disorders (Phase 3)
Melanoma (Phase 2)
Menopause, Premature (Phase 4)
Menorrhagia (Phase 2)
Mesothelioma (Phase 2)
Motor Neuron Disease (Phase 3)
Multiple Sclerosis (Phase 3)
Multiple Sclerosis, Chronic Progressive (Phase 3)
Musculoskeletal Pain (Phase 3)
Myocarditis (Phase 3)
Myofibroma (Phase 4)
Neonatal Sepsis (Phase 2)
Neoplasm Metastasis (Phase 3)
Neoplasms, Unknown Primary (Phase 2)
Neuralgia (Phase 3)
Non-alcoholic Fatty Liver Disease (Phase 3)
Organophosphate Poisoning (Phase 3)
Osteogenesis Imperfecta (Phase 4)
Ovarian Neoplasms (Phase 3)
Pancreatic Neoplasms (Phase 2)
Peripheral Nervous System Diseases (Phase 2)
Placenta, Retained (Phase 4)
Poisoning (Phase 4)
Postoperative Nausea and Vomiting (Phase 3)
Premature Birth (Phase 4)
Primary Ovarian Insufficiency (Phase 4)
Proteinuria (Phase 2)
Pseudomonas Infections (Phase 4)
Pulmonary Edema (Phase 4)
Renal Insufficiency (Phase 4)
Renal Insufficiency, Chronic (Phase 4)
Reperfusion Injury (Phase 3)
Respiratory Aspiration (Phase 2)
Respiratory Distress Syndrome (Phase 2)
Respiratory Distress Syndrome, Newborn (Phase 2)
Respiratory Tract Infections (Phase 2)
Retinal Diseases (Phase 4)
Schizophrenia (Phase 2)
Sclerosis (Phase 3)
Sepsis (Phase 2)
Severe Acute Respiratory Syndrome (Phase 3)
Stroke (Phase 3)
Stroke, Lacunar (Phase 3)
Subarachnoid Hemorrhage (Phase 3)
Surgical Wound Infection (Phase 3)
Syndrome (Phase 2)
Ulcer (Phase 2)
Vomiting (Phase 3)
Wounds and Injuries (Phase 3)